The 2nd BioLink

Highlights: A multi-dimensional interactive platform-Keynote speeches+ panel discussions+

project showcase+ exhibition Authoritative trend analysis of Chinese biopharmaceutical industry-analysis on

landscape of therapeutic biologics on a global scale A comprehensive showcase of internationally-leading biopharma technologies-

immunotherapy+ precision medicine+ R&D and production of therapeutic biologics A detailed guide to decision-making of venture capital-great financing opportunities

for biotech start-ups An array of projects promotion towards tech transfer, financing and M&A The greatest occasion to meet 200+ industry players

AGENDA

DAY ONE DAY TWO

9:00-12:00 Meeting：Module 1

Exhibition

9:00-10:30 Meeting：Module 5

Exhibition 13:30-15:30 Meeting：Module 2 10:50-12:00

Project Showcase：

Module 6 15:50-18:30 Parallel Meetings：Module 3-4

Chairperson：Mr. Xia Mingde, Senior Director of New Ventures, Johnson & Johnson Innovation

DAY 1：DEC.1, 2015

Module 1: Industry Development and Updates on Regulatory Policies and Standards

Areas to be covered: Latest regulatory policies, assessment, standards and case studies

9:00 -9:10

Opening Address from Chairman

Xia Mingde, Senior Director of New Ventures, Johnson & Johnson Innovation

9:10 -9:40

Opening Keynote

Xu Ming, Vice President, CCCMHPIE

9:40 -10:10

Building an innovation-driven ecosystem for bio-pharma industry in China

Joseph Cho, Managing Director, RDPAC

10:10 -10:40

China's Health Policy and Progress in Industry innovation

John Cai, Director, Center for Healthcare Management and Policy of CEIBS

10:40 -11:10

Regulating Therapeutic Biologics-A View Of Chinese New Pharmacopeia

Official, Chinese Pharmacopoeia Commission

11:10 -11:30

Tea Break and Networking

Visit the exhibition area and to network with 200+ industrial peers

11:30 -12:00

Keynote David Flores, CEO, BioCentury

12:00 -13:30

Lunch

Module 2: Global Biopharmaceutical Market Dynamics

13:30 -14:00

Regulation Of Biosimilars In the EU And Case Studies

-European Medicines Agency (TBC)

14:00 -14:30

Key Consideration on Biologicals Review and Case Studies

-FDA

14:30 -15:00

Overview of Biologics Standard Development at United States Pharmacopeia

-Bingbing Feng, Vice President and General Manager, USP-China

15:00 -15:30

Biopharmaceutical Product Strategies on a Global Scale in 2015

-Zhou Feng, Product & Solution Specialist, Thomson Reuters

15:30 -15:50

Tea Break and Networking

Visit the exhibition area and to network with 200+ industrial peers

15:50 -18:30

Parallel Sessio

n

Module 3: Immune therapy and Precision Medicine

Module 4: R&D and Production of Therapeutic Biologics

Areas to be covered: Immunology, Precision, Innovation, Clinical Moderator:

Xu Ming, Vice President, CCCMHPIE Keynote speakers: Wang Hongqi,Vice President,BGI Li Kang, Head of Biologics, BeiGene Panelists: - Wang Hongqi,Vice President,BGI -Li Kang, Head of Biologics, BeiGene -Mr. Wang Yinxiang, Chief scientist and CEO,Betta Pharmaceuticals -Wu Zhuoyan, Vice President, Beijing SL Pharmaceutical -Zhang Lianshan, Jiangsu Hengrui Medicine

Co.,Ltd. (TBC) -Expert, Beijing Cancer Hospital (TBC)

Areas to be covered: R&D, Manufacturing process, Expression, Trend Moderator:

Xia Mingde, Senior Director of New Ventures, Johnson & Johnson Innovation Keynote speakers: -Qiu Xiaobo, Professor, College of Life Sciences, Beijing Normal University -Dr. Tian Feng, CSO, Ambrx Panelists: -Qiu Xiaobo, Professor, College of Life Sciences, Beijing Normal University -Mr. Tian Feng, CFO, Ambrx -Julius Li, CEO, AutekBio China, Inc- Boehringer-Ingelheim China

-Merck (TBC) -Roche (TBC) -CELLTRION (TBC)

DAY 2：DEC.2, 2015

9:00 -10:00

Module 5: Biopharmaceuticals and Financing

Areas to be covered：Discovery, Technology, Capital, Integration

Speakers to be invited:

-Che Yan, CSO, Bayer China

-Liu Xin, Managing Director, China office of Greater Pacific Capital China

-Sylvia He, Partner, CDH Venture

-Yin Jinqun, Vice President, KangHong Pharmaceutical Group

-Shao Qun, Director Deputy Director, Open Innovation University of Bradford

- Cao Xiaochun, Deputy General Manager, Hangzhou Tigermed Consulting

- David Flores, CEO, BioCentury

10:00 -10:20

Tea Break and Networking

Visit the exhibition area and to network with 200+ industrial peers

10:20 -12:30

Module 6: Roadshow

Highlights of well selected Chinese and overseas projects for technology transfer, financing

and M&A